Order the FDA to acknowledge the existing evidence and ongoing trials of components of cannabis in treating several types of seizures.
FDA-approved, open-label trials for Epidiolex (it's main ingredient is a primary component of marijuana) by itself along with historical case study give overwhelming proof that it has value in treating several types of seizures.
The Catch-22: the DEA says it cannot re-classify marijuana to Schedule 2 unless the FDA determines it has a medical use. The FDA continues to obfuscate the issue with jurisdictional nonsense.
The FDA has everything they need to rule on it's medical value.
In the meantime tens of thousands of your family and neighbors are in jail or economically doomed because they now have criminal records because of the schedule 1 classification



